Interestingly, perhaps because of a negative feed-back mechanism in an auto-immune context, MPN patients with GlcSph-reactive auto-antibodies had a reduced level of IFN-α2, an immunostimulant (Figure 6). Here, IFNA2 is linked to myeloproliferative neoplasm.